JP2010539077A - ザクロ抽出物、該抽出物を含有する栄養製品及びその用途 - Google Patents

ザクロ抽出物、該抽出物を含有する栄養製品及びその用途 Download PDF

Info

Publication number
JP2010539077A
JP2010539077A JP2010523602A JP2010523602A JP2010539077A JP 2010539077 A JP2010539077 A JP 2010539077A JP 2010523602 A JP2010523602 A JP 2010523602A JP 2010523602 A JP2010523602 A JP 2010523602A JP 2010539077 A JP2010539077 A JP 2010539077A
Authority
JP
Japan
Prior art keywords
pomegranate extract
pomegranate
punicalagin
diet
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010523602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539077A5 (enExample
Inventor
マス，ヨゼ エー． ロペス
エー． ストライテンベルガー，セルジオ
メラード，マルコス ペナルベル
ロペス，ヨランダ ペドレノ
オルティツ，ペドロ マエルティネス
Original Assignee
プロベルテ ファーマ，エス．エー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08004242A external-priority patent/EP1967079B1/en
Application filed by プロベルテ ファーマ，エス．エー． filed Critical プロベルテ ファーマ，エス．エー．
Publication of JP2010539077A publication Critical patent/JP2010539077A/ja
Publication of JP2010539077A5 publication Critical patent/JP2010539077A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/45—Semi-moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/03—Coating with a layer; Stuffing, laminating, binding, or compressing of original meat pieces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/70—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor
    • A23L13/72—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor using additives, e.g. by injection of solutions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/75—Coating with a layer, stuffing, laminating, binding or compressing of original fish pieces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2010523602A 2007-09-07 2008-09-05 ザクロ抽出物、該抽出物を含有する栄養製品及びその用途 Pending JP2010539077A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07017570A EP2033526A1 (en) 2007-09-07 2007-09-07 Nutritional products comprising pomegranate extracts containing ellagitannins and their use
EP08004242A EP1967079B1 (en) 2007-03-08 2008-03-07 Process for preparing pomegranate extracts
PCT/IB2008/002316 WO2009031023A2 (en) 2007-09-07 2008-09-05 Pomegranate extracts, nutritional products containing them and their uses

Publications (2)

Publication Number Publication Date
JP2010539077A true JP2010539077A (ja) 2010-12-16
JP2010539077A5 JP2010539077A5 (enExample) 2011-10-20

Family

ID=38983775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523602A Pending JP2010539077A (ja) 2007-09-07 2008-09-05 ザクロ抽出物、該抽出物を含有する栄養製品及びその用途

Country Status (5)

Country Link
US (1) US20100210586A1 (enExample)
EP (2) EP2033526A1 (enExample)
JP (1) JP2010539077A (enExample)
ES (1) ES2343101T3 (enExample)
WO (1) WO2009031023A2 (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010070540A (ja) * 2008-08-22 2010-04-02 Kao Corp Ｄｇａｔ阻害剤
JP2013035810A (ja) * 2011-08-10 2013-02-21 Bourbon Corp 血圧上昇抑制剤
JP2013538805A (ja) * 2010-08-15 2013-10-17 ガニール、（１９９２）、リミテッド 植物生産物及び作物を保護するための天然成分を含む組成物
JP2014501764A (ja) * 2010-12-23 2014-01-23 アマゼンティス エスアー ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
JP2015504424A (ja) * 2011-11-14 2015-02-12 ヴィルバック エスアー ペット用の、プニカ・グラナツム（Ｐｕｎｉｃａｇｒａｎａｔｕｍ）（ザクロ）抽出物を含む経口投与用製品、およびその使用
JPWO2013141267A1 (ja) * 2012-03-21 2015-08-03 株式会社明治 ポリフェノール安定化剤、該安定化剤を含有する組成物および加工製品
JP2016518110A (ja) * 2013-03-14 2016-06-23 シャクリー コーポレイション マスカダインポマース抽出物の調製方法
KR20180016334A (ko) * 2015-02-06 2018-02-14 나투렉스 에스아 항균 조성물
JP2019142863A (ja) * 2019-02-28 2019-08-29 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 口内炎症を減少または治療するための組成物および方法

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303252A1 (en) * 2008-05-15 2011-04-06 Alois Jungbauer Compounds for the treatment of metabolic syndrome and insulin resistance
US20120058240A1 (en) * 2009-05-15 2012-03-08 Her Majesty The Queen In Right Of The Province Of Nova Scotia, As Represented By The Nova Scotia Agr Stable functional beverage compositions and methods of making same
CN102762573B (zh) 2009-07-24 2015-09-16 阿马曾提斯公司 用于在神经退行性障碍中保护脑部健康的化合物、组合物和方法
ES2356536B1 (es) * 2009-09-23 2012-02-13 Probelte Pharma, Sa Una composición de uso como prebiótico que contiene un extracto de granada y un alimento que incluye dicha composición.
FR2951938B1 (fr) * 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
BE1019113A3 (fr) * 2009-12-16 2012-03-06 Ludwig Manfred Jacob Composition contenant des polyphenols de grenade, de la vitamines d et des oligoelements.
JP5770462B2 (ja) * 2010-07-22 2015-08-26 株式会社クワン 種子入りザクロジュースの製造方法、その製造方法から成る種子入りザクロジュース及び前記種子入りザクロジュースを使用して成るザクロ果汁入りゼリー
ES2414662B1 (es) 2011-12-20 2014-05-27 Consejo Superior De Investigaciones Científicas (Csic) Ingrediente antioxidante de bajo contenido calórico, procedimiento de obtención y uso.
US20130266676A1 (en) * 2012-04-10 2013-10-10 Natreon, Inc. Terminalia chebula compositions and method of extracting same
WO2016099477A1 (en) 2014-12-17 2016-06-23 Hill's Pet Nutrition, Inc. Composition and method for reducing or treating oral inflammation
FR3035776B1 (fr) * 2015-05-04 2017-04-21 Raphael Colicci Procede d'obtention de jus de grenade et de leurs formes derivees et les jus et formes derivees ainsi obtenus
ES2604303B1 (es) * 2015-09-04 2017-09-06 Biovet, S.A. Producto alimenticio para animales que comprende ácido elágico, p-cimenol y aliína, y procedimiento para su obtención
JP7761372B2 (ja) 2017-03-08 2025-10-28 アマゼンティス エスアー 対象におけるマイトファジーを改善するための方法
EP4216735A1 (en) * 2020-09-24 2023-08-02 Mars Incorporated Food compositions and applications thereof
BE1028716B1 (fr) * 2020-10-20 2022-05-16 Marc Joseph Kalaycioglu Sauce à l’huile d’olive et grenade
EP4122457A1 (en) * 2021-07-23 2023-01-25 Euromed, S.A. Composition comprising hydroxytyrosol and punicalagin for use in the treatment of dislypidemia
WO2024171222A1 (en) * 2023-02-15 2024-08-22 Jeyakodi Shankaranarayanan Skin health benefitting compositions
CN117941723A (zh) * 2024-02-23 2024-04-30 宿迁市汇味食品有限公司 一种石榴皮多酚苏打饼干及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542283A (ja) * 2005-05-24 2008-11-27 ポム ワンダフル エルエルシー ザクロ固形物から植生化学物質を抽出する方法およびその組成物並びに使用方法
JP2010534488A (ja) * 2007-07-27 2010-11-11 ザ ステート オブ イスラエル， ミニストリー オブ アグリカルチャー アンド ルーラル ディヴェロプメント， アグリカルチュラル リサーチ オーガニゼーション， （エー．アール．オー．）， ボルカニ ザクロ新芽、ザクロ新芽由来の調製物およびそれらを含む組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159465A1 (en) * 1993-04-01 1994-10-13 Paul H. Todd, Jr. Lipid-soluble green tea catechin antioxidant solutions
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
US6696485B1 (en) * 1996-04-02 2004-02-24 Mars, Incorporated Procyanidin and cyclo-oxygenase modulator compositions
US6641850B1 (en) * 1999-04-19 2003-11-04 Stewart And Lynda Resnick Revocable Trust Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
WO2001078529A2 (en) * 2000-04-14 2001-10-25 Mars, Incorporated Compositions and methods for improving vascular health
ATE343325T1 (de) * 2000-06-20 2006-11-15 Calpis Co Ltd Saures milchgetraenk
US6387370B1 (en) * 2001-01-19 2002-05-14 A. Glenn Braswell Compositions containing extracts of Morinda citrifolia, red wine, prune, blueberry, pomegranate, apple and enzyme mixture
JP2003102431A (ja) * 2001-09-28 2003-04-08 Persia Zakuro Yakuhin:Kk ザクロエキス
US20060177530A1 (en) * 2003-07-14 2006-08-10 Roberto Crea Method of treating diabetes type II
JP2005154323A (ja) * 2003-11-25 2005-06-16 Hosoda Shc:Kk 抗菌消臭剤
EP1734949B1 (en) * 2004-03-24 2015-05-20 The Regents of The University of California Purifications of ellagitannins
EP1967078A1 (en) * 2007-03-08 2008-09-10 Probelte Pharma, S.A. Process and apparatus for preparing pomegranate extracts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542283A (ja) * 2005-05-24 2008-11-27 ポム ワンダフル エルエルシー ザクロ固形物から植生化学物質を抽出する方法およびその組成物並びに使用方法
JP2010534488A (ja) * 2007-07-27 2010-11-11 ザ ステート オブ イスラエル， ミニストリー オブ アグリカルチャー アンド ルーラル ディヴェロプメント， アグリカルチュラル リサーチ オーガニゼーション， （エー．アール．オー．）， ボルカニ ザクロ新芽、ザクロ新芽由来の調製物およびそれらを含む組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013024843; Ｓｅｅｒａｍ　ｅｔ　ａｌ．: ''Ｉｎ　ｖｉｔｒｏ　ａｎｔｉｐｒｏｌｉｆｅｒａｔｉｖｅ　ａｐｏｐｔｏｔｉｃ　ａｎｄ　ａｎｔｉｏｘｉｄａｎｔ　ａｃｔｉｖｉｔｉｅｓ　ｏｆ　ｐｕｎｉｃａｌａｇｉｎ，　ｅｌｌａｇｉｃ　ａｃｉｄ　ａｎｄ　ａ' Ｊｏｕｒｎａｌ　ｏｆ　Ｎｕｔｒｉｔｉｏｎａｌ　Ｂｉｏｃｈｅｍｉｓｔｒｙ Ｖｏｌ．１６, 2005, ｐｐ．３６０-３６７ *
JPN6013024844; Ｓｅｅｒａｍ　ｅｔ　ａｌ．: ''Ｒａｐｉｄ　ｌａｒｇｅ　ｓｃａｌｅ　ｐｕｒｉｆｉｃａｔｉｏｎ　ｏｆ　ｅｌｌａｇｉｔａｎｎｉｎｓ　ｆｒｏｍ　ｐｏｍｅｇｒａｎａｔｅ　ｈｕｓｋ，　ａ　ｂｙ-ｐｒｏｄｕｃｔ　ｏｆ　ｔｈｅ　ｃｏｍｍｅｒｃｉ' Ｓｅｐａｒａｔｉｏｎ　ａｎｄ　Ｐｕｒｉｆｉｃａｔｉｏｎ　Ｔｅｃｈｎｏｌｏｇｙ Ｖｏｌ．４１, 2005, ｐｐ．４９-５５ *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010070540A (ja) * 2008-08-22 2010-04-02 Kao Corp Ｄｇａｔ阻害剤
JP2013538805A (ja) * 2010-08-15 2013-10-17 ガニール、（１９９２）、リミテッド 植物生産物及び作物を保護するための天然成分を含む組成物
KR101955001B1 (ko) 2010-12-23 2019-03-07 아마젠티스 에스에이 미토콘드리아 기능을 개선하고 신경퇴화 질환들 및 인지 장애들을 치료하는 조성물들 및 방법들
JP2014501764A (ja) * 2010-12-23 2014-01-23 アマゼンティス エスアー ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
KR102072612B1 (ko) 2010-12-23 2020-02-04 아마젠티스 에스에이 미토콘드리아 기능을 개선하고 신경퇴화 질환들 및 인지 장애들을 치료하는 조성물들 및 방법들
KR20190026045A (ko) * 2010-12-23 2019-03-12 아마젠티스 에스에이 미토콘드리아 기능을 개선하고 신경퇴화 질환들 및 인지 장애들을 치료하는 조성물들 및 방법들
JP2013035810A (ja) * 2011-08-10 2013-02-21 Bourbon Corp 血圧上昇抑制剤
JP2015504424A (ja) * 2011-11-14 2015-02-12 ヴィルバック エスアー ペット用の、プニカ・グラナツム（Ｐｕｎｉｃａｇｒａｎａｔｕｍ）（ザクロ）抽出物を含む経口投与用製品、およびその使用
JPWO2013141267A1 (ja) * 2012-03-21 2015-08-03 株式会社明治 ポリフェノール安定化剤、該安定化剤を含有する組成物および加工製品
JP2016518110A (ja) * 2013-03-14 2016-06-23 シャクリー コーポレイション マスカダインポマース抽出物の調製方法
JP2018505679A (ja) * 2015-02-06 2018-03-01 ナチュレクス セーアー 抗微生物組成物
KR20180016334A (ko) * 2015-02-06 2018-02-14 나투렉스 에스아 항균 조성물
JP2021008484A (ja) * 2015-02-06 2021-01-28 ナチュレクス セーアー 抗微生物組成物
JP7224322B2 (ja) 2015-02-06 2023-02-17 ナチュレックス エスアー 抗微生物組成物
KR102554194B1 (ko) 2015-02-06 2023-07-10 나투렉스 에스아 항균 조성물
JP2019142863A (ja) * 2019-02-28 2019-08-29 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 口内炎症を減少または治療するための組成物および方法

Also Published As

Publication number Publication date
EP2203070A2 (en) 2010-07-07
WO2009031023A3 (en) 2009-07-23
ES2343101T3 (es) 2013-07-15
US20100210586A1 (en) 2010-08-19
EP2033526A1 (en) 2009-03-11
EP2203070B1 (en) 2013-03-27
WO2009031023A2 (en) 2009-03-12
ES2343101T1 (es) 2010-10-13

Similar Documents

Publication Publication Date Title
JP2010539077A (ja) ザクロ抽出物、該抽出物を含有する栄養製品及びその用途
US8828472B2 (en) Food products containing omega-3 fatty acids
EP2799083A1 (en) Muscular atrophy preventing agent
JP5965916B2 (ja) キウイフルーツ由来の心保護剤
CN103998051A (zh) 桑属浆果及其避免血糖峰值的用途
Chen et al. Functional foods and intestinal homeostasis: The perspective of in vivo evidence
CN110876258B (zh) 提高肠内吸收率的甜菜根汁、其制备方法及其用途
JP5709864B2 (ja) 粗カフェイン複合体、粗カフェイン複合体を用いた改善された食品製品、およびその使用方法
WO2008013219A1 (fr) Composition orale permettant une absorption accrue de la cryptoxanthine
JP5594819B2 (ja) 脂質代謝改善用組成物
Bhattacharjee et al. Role of dietary serotonin and melatonin in human nutrition
JP4141271B2 (ja) 柑橘類抽出組成物
Brewer-Smyth Brain Food: The Impact of Diet, Nutrition, and Nutraceuticals on the Brain and the Microbiota-Gut-Brain Axis
Gvozdjakova et al. Cocoa consumption and prevention of cardiometabolic diseases and other chronic diseases
JP5013588B2 (ja) 血中脂質改善剤
AU2018414280B2 (en) Composition for reducing deterioration of mental function
JP2012162472A (ja) 脂質排泄促進剤
KR101344564B1 (ko) 마라소스의 주성분인 고추 및 화초 추출물을 유효성분으로 함유하는 비만 또는 고지혈증 예방 및 치료용 조성물
Kobayashi et al. Hypolipidemic effect of Shoyu polysaccharides from soy sauce in animals and humans
WO2015190682A1 (ko) 쿠마린산을 유효성분으로 포함하는 성장 촉진용 조성물
JP2003095941A (ja) 糖質消化酵素阻害剤、血糖値上昇抑制剤、肥満治療予防剤、糖尿病治療予防剤、健康飲食物
JPWO2009057295A1 (ja) 脂質代謝改善剤
Naruszewicz et al. Potential parapharmaceuticals in the traditional Polish diet
JP2008050301A (ja) 膵リパーゼ阻害剤
Wei et al. Adverse health consequences of dietary advanced glycation end products (AGEs) and inhibitory effects of natural ingredients on ages

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130524

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131028